Viewing Study NCT00778167


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2025-12-26 @ 1:31 PM
Study NCT ID: NCT00778167
Status: COMPLETED
Last Update Posted: 2014-05-21
First Post: 2008-10-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor: National Cancer Institute (NCI)
Organization: